International Patent: ORALLY DELIVERABLE NON-NATURALLY OCCURRING MELANOCORTIN ANALOGS AND USES THEREOF FOR REGULATING GLUCOSE METABOLISM

GENEVA, Oct. 9 -- ENDEVICA BIO, INC. filed a patent application (US2026/021806) for “ORALLY DELIVERABLE NON-NATURALLY OCCURRING MELANOCORTIN ANALOGS AND USES THEREOF FOR REGULATING GLUCOSE METABOLISM”. With publication no. WO/2026/213237, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 38/33

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....